跳至主要内容
临床试验/NCT00503828
NCT00503828已完成3 期

The Efficacy and Safety of Derris Scandens Benth Extract and Naproxen for Therapy of Patients With Knee Osteoarthritis

Mahidol University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2007年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
120
试验地点
1
主要终点
WOMAC score

研究概览

简要总结

Derris Scandens Benth (family : Leguminosae) is a woody vine growing throughout Southeast Asia, including Thailand. The stem of D.Scandens has been widely use in Thai traditional medicine, foe example of myalgia. Previous study shown that D.Scandens Benth extract has the anti-inflammatory activity. Although NSAIDs are efficaciously in the treatment of osteoarthritis,but the GI side effect is still concerned. In this study we aim to investigate the efficacy and safety of D. Scandens Benth extract compared with Naproxen for therapy of patients with knee osteoarthritis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >=50 yr
  • Known case of primary knee osteoarthritis
  • WOMAC pain subscale (item1) >= 5
  • signed informed consent

排除标准

  • hypersensitive to NSAIDs
  • history of peptic ulcer or melena
  • unable to walk , i.e. patient with severe spinal stenosis, myocardial infarction
  • history of intra-articular injection of knee within 3 months
  • status post knee replacement

研究组 & 干预措施

naproxen

Active Comparator

Naproxen 500 mg/day for 4 weeks

干预措施: naproxen (Drug)

Derris Scandens Benth

Experimental

Derris Scandens Benth

干预措施: Derris scandens Benth extracts (Drug)

结局指标

主要结局

WOMAC score

时间窗: 2, 4 weeks

次要结局

  • 6-minute walk, Quality of Life, adverse event(2, 4 weeks)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验